Clinical Trial Update: Advagraf/Prograf Conversion Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating conversion from Prograf to Advagraf in renal and kidney-pancreas transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Pancreas Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Norman Muirhead | Conditions: Renal Transplant, Kidney Pancreas Transplant | Phase 4 | Status: COMPLETED